CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity

por Dong, Zhao-Ru, Ke, Ai-Wu, Li, Tao, Cai, Jia-Bing, Yang, Ya-fei, Zhou, Wei, Shi, Guo-Ming, Fan, Jia
Publicado 2021

Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis

por Huang, Xiao-Yong, Zhang, Peng-Fei, Wei, Chuan-Yuan, Peng, Rui, Lu, Jia-Cheng, Gao, Chao, Cai, Jia-Bing, Yang, Xuan, Fan, Jia, Ke, Ai-Wu, Zhou, Jian, Shi, Guo-Ming
Publicado 2020

Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors

por Lu, Jia-Cheng, Zeng, Hai-Ying, Sun, Qi-Man, Meng, Qing-Nan, Huang, Xiao-Yong, Zhang, Peng-Fei, Yang, Xuan, Peng, Rui, Gao, Chao, Wei, Chuan-Yuan, Shen, Ying-Hao, Cai, Jia-Bing, Dong, Rui-Zhao, Shi, Ying-Hong, Sun, Hui-Chuan, Shi, Yujiang G., Zhou, Jian, Fan, Jia, Ke, Ai-Wu, Yang, Liu-Xiao, Shi, Guo-Ming
Publicado 2019